4.7 Article

Prior immunosuppressive therapy is associated with mortality in COVID-19 patients: A retrospective study of 835 patients

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Ophthalmology

COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs

Zheng Xian Thng et al.

Summary: The emergence of SARS-CoV-2 in 2019 has raised concerns about the vulnerability of patients under immunosuppressive treatment during the COVID-19 pandemic. However, preliminary clinical experiences suggest that immunosuppressed patients may not have significantly different morbidity and mortality rates compared to the general population. Current global best practice guidelines recommend continuing immunosuppression treatment for patients who require it, except in cases involving high-dose corticosteroid therapy and patients with risk factors for severe COVID-19 disease.

BRITISH JOURNAL OF OPHTHALMOLOGY (2021)

Article Immunology

Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients With Human Immunodeficiency Virus and Coronavirus Disease 2019

Dima Dandachi et al.

Summary: The study found that people living with HIV have a higher risk of severe outcomes from COVID-19, especially those with older age, chronic lung disease, hypertension, and lower CD4 cell counts. Antiretroviral therapy and viral suppression did not have a significant impact on the outcomes examined.

CLINICAL INFECTIOUS DISEASES (2021)

Article Allergy

Coronavirus disease 2019 in patients with inborn errors of immunity: An international study

Isabelle Meyts et al.

Summary: The study shows that patients with IEI exhibit varied responses to SARS-CoV-2 infection, with some requiring hospitalization and even intensive care, and a non-negligible mortality rate. In comparison to the general population, younger IEI patients may face a higher risk of severe illness and mortality.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Letter Allergy

Clinical outcomes and features of COVID-19 in patients with primary immunodeficiencies in New York City

Hsi-en Ho et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

Article Rheumatology

Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

Anja Strangfeld et al.

Summary: Factors associated with COVID-19-related death in people with rheumatic diseases include age, sex, comorbidities, disease activity, and specific medications. Adequate disease control with disease-modifying anti-rheumatic drugs (DMARDs) without increasing glucocorticoid dosages is important, while caution may be required with certain medications such as rituximab and sulfasalazine.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Article Medicine, General & Internal

Trends in COVID-19 Risk-Adjusted Mortality Rates

Leora Horwitz et al.

Summary: A study in a three-hospital academic health system in New York showed a decrease in hospital mortality rates among COVID-19 patients, with adjusted mortality dropping from 25.6% in March to 7.6% in August. The standardized mortality ratio also decreased from 1.26 in March to 0.38 in August, indicating an improving trend in patient outcomes. These findings suggest that mortality from COVID-19 may be decreasing even after adjusting for patient characteristics.

JOURNAL OF HOSPITAL MEDICINE (2021)

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Article Biochemistry & Molecular Biology

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

Daniel Blanco-Melo et al.

Article Biochemistry & Molecular Biology

Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients

Pierre Bost et al.

Article Medicine, General & Internal

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

Safiya Richardson et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Medicine, Research & Experimental

Clinical and immunological features of severe and moderate coronavirus disease 2019

Guang Chen et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Letter Medicine, General & Internal

Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?

Andrew I. Ritchie et al.

LANCET (2020)

Letter Medicine, General & Internal

COVID-19: consider cytokine storm syndromes and immunosuppression

Puja Mehta et al.

LANCET (2020)

Article Multidisciplinary Sciences

Viral and host factors related to the clinical outcome of COVID-19

Xiaonan Zhang et al.

NATURE (2020)

Review Medicine, General & Internal

Prevalence of Asymptomatic SARS-CoV-2 Infection A Narrative Review

Daniel P. Oran et al.

ANNALS OF INTERNAL MEDICINE (2020)

Editorial Material Immunology

Cytokine Storms: Understanding COVID-19

Nilam Mangalmurti et al.

IMMUNITY (2020)

Letter Clinical Neurology

COVID-19 in persons with multiple sclerosis treated with ocrelizumab - A pharmacovigilance case series

Richard Hughes et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)

Article Medicine, Research & Experimental

Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections

Kenneth E. Remy et al.

JCI INSIGHT (2020)

Review Infectious Diseases

The pathogenesis and treatment of the 'Cytokine Storm' in COVID-19

Qing Ye et al.

JOURNAL OF INFECTION (2020)

Letter Infectious Diseases

Viral dynamics in mild and severe cases of COVID-19

Yang Liu et al.

LANCET INFECTIOUS DISEASES (2020)

Article Biochemistry & Molecular Biology

A single-cell atlas of the peripheral immune response in patients with severe COVID-19

Aaron J. Wilk et al.

NATURE MEDICINE (2020)

Article Medicine, General & Internal

Multisystem Inflammatory Syndrome in US Children and Adolescents

Leora R. Feldstein et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 A Meta-analysis

Jonathan A. C. Sterne et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Medicine, General & Internal

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

John H. Stone et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Public, Environmental & Occupational Health

Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection - United Kingdom and United States, March-August 2020

Sapna Bamrah Morris et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Article Oncology

Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy

Amber J. Giles et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)